For years, the healthcare industry has championed patients as valued partners in care, frequently extending invitations for them to secure a seat at the table. During a dedicated panel session at Health Datapalooza in Washington, D.C., experts gathered to scrutinize the trajectory of the modern patient data movement and evaluate the true extent of that involvement.

While patient engagement remains sporadic, it has steadily broadened into spheres previously untouched in the early 2000s, encompassing research initiatives, advisory boards, high-level policy debates, and technological governance. This expansion largely stems from tireless grassroots advocacy by the e-patient movement, which has continually insisted that medical systems must not formulate policies regarding patients without deeply integrating them into the workflow.

In subsequent discussions following the panel, Donna Cryer, JD, of CryerHealth, Andrea Downing of The Light Collective, and Erica Olenski of Monarch Futures shed light on the multifaceted layers of this evolution. Their distinct viewpoints distill three critical inquiries: What specific patient expertise is demanded, how should it be cultivated, and does it genuinely steer final outcomes?

Matching Patient Expertise To The Purpose

Cryer contends that a major pitfall lies in treating “the patient” as a monolithic, interchangeable demographic. Individuals offer wildly diverse backgrounds, skill sets, and degrees of specialization, meaning any invited individual should directly align with the specific goals of the organization.

“Stop talking about, ‘Well, we need a patient,’” Cryer noted. “For what? Let’s fit the patient to purpose.”

Outlining a progressive developmental path, Cryer explained how an individual can evolve from a basic storyteller into a trained advocate, transform into a subject-matter expert, and eventually reach what she terms a “patient executive.” These leaders merge intimate lived experience with high-level professional competence spanning technology, commerce, medicine, or jurisprudence.

“Having lived experience of the depth and breadth that we have, plus our business, legal, or engineering expertise, is what makes us effective in these roles,” she emphasized.

From Having A Voice To Having Influence

Cryer witnessed this dynamic firsthand while holding positions on two separate Food and Drug Administration advisory committees. The FDA’s formalized patient representative program carefully prepares, supports, and compensates its delegates. Crucially, on both of those committees, she possessed an official vote.

“A vote is so much better than having a voice,” she stated.

Reflecting on her tenure, Cryer discovered that patient representatives had historically occupied passive roles during committee deliberations. She leveraged both her personal trials and her firm grasp of clinical evidence to dismantle prevailing misconceptions surrounding patients suffering from severe liver diseases.

“Getting the seat is one thing,” she observed. “Having everybody else accept you and take you seriously is another thing. But then you have to be more than just warming that seat.”

Driven by this conviction, Cryer spearheaded rigorous training curricula at the Global Liver Institute. Attendees immersed themselves in policy, clinical research, reimbursement models, healthcare navigation, and strategic communications, applying this foundation to tackle their most pressing challenges. Graduates subsequently transitioned into state-level policy roles, research peer-reviews, FDA advisory panels, or founded independent advocacy groups.

“I don’t put out seat warmers,” Cryer stated. “I put out people who will use that seat.”

Lived Experience Changes What You See

Olenski approaches the discourse from the perspective of an active family caregiver paired with a robust professional background in health information technology, systems integration, and data interoperability. While tending to her son, that specialized career equipped her to pinpoint precisely where institutional choices were finalized and where infrastructural frameworks broke down.

“I could see the systemic breakdowns,” she explained. “I understood how power and money flowed through the healthcare system, and I could see opportunities to advocate that I might not otherwise have seen.”

Her professional acumen also reshaped how she engaged with her son’s medical care teams. Olenski mastered the clinical nomenclature and structural frameworks utilized by physicians among themselves, fundamentally altering her capacity to participate meaningfully in dialogues regarding her child's medical path.

“I realized there was a huge luxury and privilege in the fact that I was able to build rapport as a peer with these physicians,” she said.

This dynamic exposes a systemic dilemma: How can medical institutions accommodate patients and caregivers who lack specialized professional credentials to navigate complex bureaucracies on equal footing?

Can Patient Partnership Be Measured?

Downing argues that the healthcare sector desperately requires greater methodological rigor regarding what it genuinely means to designate patients as genuine partners.

“People say, ‘We should bring patients into the loop,’ but they don’t know how,” she remarked. “We have to teach people how.”

“We talk about partnering as something that’s kind of loosey-goosey,” Downing continued. “We need to measure and evaluate partnership.”

Such accountability could involve tracking whether patients were integrated early enough to shape foundational questions, whether they possessed sufficient data to contest existing assumptions, whether they received fair financial compensation, and whether their insights ultimately modified a policy, research initiative, commercial product, or institutional decree.

“We all have very different types of expertise,” Downing noted, “but we’re not measuring it, formalizing it, or valuing that role.”

Yet, institutionalizing patient expertise harbors hidden dangers. If healthcare organizations repeatedly turn exclusively to polished advocates fluent in policy, research, and tech terminology, they risk echoing a tiny, insular circle of veterans while entirely sidelining raw, unfiltered viewpoints.

Cryer’s methodology offers a viable counterweight by cultivating a deeper bench of prepared advocates. Rather than recycling the same familiar faces found in regulatory boardrooms, developing fresh talent exponentially expands the ecosystem of capable contributors.

Nevertheless, building this talent pool remains only half the battle. A seasoned advocate makes an ideal representative for a regulatory body, whereas a newly diagnosed patient or an uninitiated family caregiver often identifies glaring operational flaws that veteran advocates overlook. Both bring irreplaceable insights, even if only one feels comfortable operating inside formal governance structures.

Ultimately, the medical industry faces a dual mandate: equipping a wider swath of patients with the sophisticated tools required to sway complex decisions, while simultaneously forging alternative pathways for individuals to contribute without forcing them to morph into professional advocates.

In the wake of Health Datapalooza, a familiar phrase echoed in thought: the classic district slogan stamped on vehicles across Washington, D.C., reading Taxation Without Representation.

Healthcare organizations have spent decades striving toward expansive patient representation, making the acquisition of a seat at the table a monumental victory.

The defining test moving forward is whether patients are finally granted a vote.